How to get more melasma treatment patients

Melasma treatment is a service some patients pay for themselves and others ask their insurer about, and how it is described shapes who books and what they expect. Many callers mention brown or dark patches on the cheeks, forehead, nose or upper lip, patches that showed up during or after a pregnancy, patches that seem to get darker after time in the sun, patches that keep coming back, or store products that have not helped, and most calls are from adults. This guide is for owners, coordinators and front desk teams in dermatology practices and physician-supervised med spas that evaluate dark patches on the face: what MedlinePlus says about melasma, its diagnosis and its treatment, which claims to avoid, and how to turn requests into well-informed evaluations. Here, the dermatologist evaluates the patient and decides on the treatment plan, and talks it through with the patient.

SearchAn adult looks for care near them.
Your pageWhat you treat, who sees them, one way to book.
Call or formThey call or send a request.
Front deskBooks the visit and never guesses a cause.
Clinical teamThe clinician decides the plan.

How a new patient request reaches your practice.

1. Know what melasma treatment is and is not

The MedlinePlus melasma article says “Melasma is a skin condition that causes patches of dark skin on areas of the face exposed to the sun.” and “They often appear on the cheeks, forehead, nose, or upper lip.” The MedlinePlus skin pigmentation disorders topic page says “Some pigmentation disorders affect just patches of skin.”

Care starts with an evaluation, not a set package of visits. The MedlinePlus melasma article says “Your health care provider will look at your skin to diagnose the problem.” and “A closer exam using a device called a Wood’s lamp (which uses ultraviolet light) may help guide your treatment.” The MedlinePlus hyperpigmentation article says “Your provider will perform a physical exam and ask about your symptoms, including:” and lists questions such as “Did it develop suddenly?” and “What medicines do you take?”

Only a licensed clinician evaluates the skin, and the dermatologist decides whether a skin biopsy or other tests are needed. The front desk does not say whether a caller has melasma, another kind of dark spot or another skin condition or which treatment they need, and neither the front desk nor an ad can tell melasma from any other spot.

Some callers are sure their dark patches are melasma, or call about a spot that looks different from the rest. A dark patch can be something else. The MedlinePlus hyperpigmentation article says “Causes of hyperpigmentation include:” and lists skin inflammation, certain medicines, hormone system diseases, sun exposure, pregnancy and certain birthmarks among them. The MedlinePlus liver spots article says “Liver spots are flat, brown or black spots that can appear on areas of the skin that are exposed to the sun.” and “You may need a skin biopsy to confirm the diagnosis.” The MedlinePlus melasma article says “Contact your provider if you have darkening of your face that does not go away.” The MedlinePlus hyperpigmentation article says “Contact your health care provider for an appointment if you have:” and lists “Skin discoloration that causes significant concern.”, “Persistent, unexplained darkening or lightening of the skin.” and “Any skin sore or lesion that changes shape, size, or color. It may be a sign of skin cancer.” The MedlinePlus liver spots article says “Contact your provider if:” and lists “You have liver spots and want them removed” and “You develop any new symptoms, especially changes in the appearance of a liver spot”. If a caller reports a sore or spot that changes shape, size or color, or any new symptoms or changes in how a spot looks, during the call, tell them MedlinePlus says to contact their health care provider, then tell the clinical team promptly so a clinician can speak with the caller. The front desk does not say whether a spot is melasma, a liver spot or anything else, does not judge whether a change matters, and does not tell callers which products to use or how to protect their skin from the sun; staff note it on the intake form and pass it to the clinician, and pass any changing spot to the clinical team promptly.

Some callers ask for one specific treatment only, or bring a list of past prescriptions or a plan from another clinic. Book the evaluation the same way, give the price, do not promise which treatment the dermatologist will use or how the plan will look, and do not promise a plan based on an earlier prescription.

Do not present melasma treatment or a named medicine or technique as the only answer or as a sure fix. The dermatologist explains the options and decides on the plan with the patient.

Some visits involve a referral, often from a family doctor. Some patients come with a referral from their doctor and some without; staff check what the patient’s plan requires and do not promise anything either way. Make the hand off from referring clinicians easy, and never offer or accept payment for referrals. See also patient referrals for medical practices, how to get more rosacea treatment patients and how to get more acne treatment patients.

2. Keep claims in line with the risk information

MedlinePlus gives a balanced picture of melasma treatment. Its melasma, hyperpigmentation and liver spots articles point out the limits.

the MedlinePlus melasma article says “The problem may come back in future pregnancies or if you use these medicines again.” and “It may also come back from sun exposure.”;
the MedlinePlus liver spots article says the ingredient used in most products sold for such spots “can cause blisters or skin reactions in sensitive people.”

On results, the MedlinePlus melasma article says “Melasma is often associated with the female hormones estrogen and progesterone.” and “Being in the sun makes melasma more likely to develop.” What brings dark patches on, and what keeps them away, differs from patient to patient. Do not promise that dark patches will go away or stay away, a particular look, a number of visits, a time frame or any other outcome in ads or on the phone.

Treatment choice belongs in the exam room. The MedlinePlus melasma article says “Treatments may include:” and lists several kinds of care, and the MedlinePlus hyperpigmentation article says the provider recommends care “depending on the type of skin condition you have.” Do not push a named medicine, technique or add-ons; the dermatologist explains the options after the evaluation and decides on the plan with the patient.

Write about patients with respect. Do not use fear copy about dark patches spreading, how the face looks in photos, covering patches with makeup or what other people think, do not blame or shame people about their skin, time in the sun, pregnancy, birth control, hormones or age, and avoid shock images and deadline pressure. Never suggest that one skin tone is better than another. The MedlinePlus melasma article says “Melasma is a common skin disorder.” and “However, this color change can cause distress about your appearance.” Do not use a named medicine, product or technique as an ad hook, and never advertise or promise any medicine, product or prescription as a fix. Keep ad copy aimed at adults, and never target minors in ads or social campaigns. The melasma article lists pregnancy, birth control and hormone replacement during menopause among the times melasma is common; never aim ads at pregnant people. Do not build ad audiences from melasma or other skin conditions, pregnancy, birth control or hormone use, past treatments, prescriptions, diagnoses, medicines or other health information.

Be careful with children and teenagers. Some callers will be parents; the MedlinePlus melasma article says “it can affect anyone.” If a parent calls about a child or a teenager with dark patches or spots, do not tell the parent that the child needs melasma treatment or that any treatment will fix it. For a minor, a parent or guardian books and consents, and the dermatologist decides whether and when treatment makes sense. If you text or email about an appointment for a minor, use the parent’s or guardian’s contact details and consent; see texting patients and the TCPA.

Avoid “erase dark spots”, “spot-free”, “flawless skin”, “even skin tone guaranteed”, “cure”, “permanent results”, “hydroquinone”, “tretinoin”, “retinoid”, “azelaic acid”, “tranexamic acid”, “kojic acid”, “vitamin C serum”, “bleaching cream”, “lightening”, “whitening”, “chemical peels”, “laser”, “IPL”, “microneedling”, “injections”, “melasma pill”, “sunscreen that cures melasma”, “risk-free”, “guaranteed results”, “insurance will cover it”, “no referral needed” and “FDA-approved”. Better: “the dermatologist will ask about the dark patches and what you have tried, examine your skin, explain the options and decide on a treatment plan with you”.

3. Answer first-call questions honestly

How much does it cost? Give a clear starting price, say what it includes (the evaluation, follow-up visits, any in-office treatment, whether medicines and products are extra) and that what the dermatologist finds, the treatment plan the dermatologist recommends and how many visits it includes affect the total. Say whether the evaluation, follow-up visits and any in-office treatment are priced separately.
Does insurance pay? Do not promise coverage. Coverage varies by plan, so the practice checks each patient’s plan.
Do I need melasma treatment? “We cannot tell that on the phone. The dermatologist will ask about the dark patches, where they are, when they started, whether they have changed, what you have already tried, your health and medicines, examine your skin and talk with you about the options and whether treatment makes sense.”
Can I be treated if I am pregnant or take other medicines? Do not answer either way. Pregnancy, breastfeeding, plans to become pregnant and current medicines are questions for the dermatologist; staff note them on the intake form and the dermatologist talks them through at the evaluation.
Who does the work? Give the dermatologist’s name and real credentials. Let callers check them with the state medical board.

When a caller asks about insurance, staff take the plan details and say the practice will check; they never say the treatment will be covered.

Leave screening to the dermatologist. Your intake form can ask the patient’s age, the reason for the visit, where the dark patches are (cheeks, forehead, nose, upper lip or elsewhere), how long the patient has had them, whether they began suddenly, have spread or have changed, whether any spot is sore or has changed shape, size or color, time in the sun, what has been tried, past melasma treatments and prescriptions, any referral from the patient’s doctor, the referring clinician, current medicines, including hormone medicines such as birth control, health conditions and whether the patient is pregnant, breastfeeding or planning a pregnancy; for a minor, the parent or guardian fills it in. The MedlinePlus melasma article lists “Stopping hormone medicines that may be causing the problem” among treatments; that is a decision for the patient’s clinicians, never for the front desk. Never tell a caller to stop a medicine by a certain date, and never suggest a medicine, a skin product, a device or a home remedy. Skin care advice is for the dermatologist to give. The front desk does not judge how urgent a call is. Pass any report of blisters, burning, stinging, redness, a rash or other skin reactions where a skin product was applied, any other new or unusual problem while using a skin product or medicine, a possible pregnancy while using a skin product or medicine, dark patches that began suddenly or are spreading, a sore or spot that changes shape, size or color or any new symptoms or changes in how a spot looks, symptoms that get worse, or a caller who says they feel low, anxious, stressed or upset about their skin to the clinical team promptly. If a caller says they are thinking about killing or hurting themselves, stay with them and tell them to dial 911 if it is an emergency or to call or text the 988 Suicide and Crisis Lifeline at 988, as MedlinePlus advises, then tell the clinical team. If a caller reports any of the signs listed in section 1 under “Contact your health care provider for an appointment if you have:” or “Contact your provider if:” during the call, tell them MedlinePlus says to contact their health care provider, then tell the clinical team promptly. The dermatologist decides whether someone is a candidate and which treatment is suitable. Front desk staff only collect the answers. Use the new patient phone script for the rest of the call, and book the evaluation, not the treatment, while the caller is on the line.

4. Plan the evaluation, treatment visits and follow-up

The MedlinePlus hyperpigmentation article says “Tests that may be done include:” and lists “Skin biopsy” and “Wood lamp test” among them. The MedlinePlus melasma article says a Wood’s lamp exam “may help guide your treatment.” Tell callers that the choice of care comes after the exam.

Make second opinions easy, and give patients time to talk through the plan, skin care at home and any medicines with the dermatologist first.

For the evaluation and treatment visits, ask your dermatologists for written notes on preparing for the visit, what to bring, such as a list of the products and medicines already tried and current medicines, any referral the patient’s plan asks for, skin care at home as the dermatologist sets it, warning signs and follow-up visits. The MedlinePlus hyperpigmentation article lists “How often are you in the sun?” among the questions the provider may ask. Share them with callers and parents early. Aftercare depends on the treatment; the dermatologist gives exact instructions and sets the follow-up schedule.

5. Price, finance and follow up

Self-pay patients may be entitled to a good faith estimate; see the good faith estimate guide.
If you advertise a discount, follow advertising prices and specials. Avoid deadline pressure on a treatment decision.
If you offer financing, follow the patient financing guide.
Before-and-after photos need written authorization and honest comparisons; see before-and-after photos. FTC guides treat a patient’s result as typical unless you disclose what patients can generally expect.
Follow up after the evaluation without pressure; see consultation to treatment. Track melasma treatment requests and referrals separately, from request to evaluation to treatment, and keep the notes the dermatologist needs for follow-up visits.

Where MediLeadGen fits

MediLeadGen sends practices requests from people interested in cash-pay elective treatments. Each request goes to one practice only, with the person’s consent naming that practice, at a fixed price per delivered request.

See how it works for practices

Questions practices ask

How do we get more melasma treatment patients?

Answer requests quickly, give clear prices and what they include, introduce the dermatologist by real credentials, keep claims in line with the risk information, make referrals and second opinions easy, and book an evaluation where the dermatologist can ask about the dark patches, where they are, when they started, whether they have changed and what has been tried, examine the skin and explain the options before deciding on a treatment plan.

Can we promise callers that the dark patches will go away and stay away?

No. MedlinePlus says melasma may come back in future pregnancies, if hormone medicines are used again or from sun exposure, and a dark patch can be something else, such as a liver spot or another kind of hyperpigmentation. Staff collect intake answers only, and the dermatologist decides on the treatment plan with the patient after the evaluation.

What should the front desk do when a caller reports a spot that has changed, a reaction to a skin product or feeling upset about their skin?

Collect the intake answers and pass any report of blisters, burning, stinging, redness, a rash or other skin reactions where a skin product was applied, any other new or unusual problem while using a skin product or medicine, a possible pregnancy while using a skin product or medicine, dark patches that began suddenly or are spreading, symptoms that get worse, or a caller who says they feel low, anxious, stressed or upset about their skin to the clinical team promptly. If a caller reports a skin sore or spot that changes shape, size, or color, any new symptoms or changes in the appearance of a spot, or darkening of the face that does not go away during the call, tell them MedlinePlus says to contact their health care provider, then tell the clinical team promptly so a clinician can speak with the caller. If a caller says they are thinking about killing or hurting themselves, stay with them and tell them to dial 911 if it is an emergency or to call or text the 988 Suicide and Crisis Lifeline at 988, as MedlinePlus advises, then tell the clinical team. The front desk does not judge how urgent a call is, say whether a spot is melasma or something else or whether a change is serious, or suggest a treatment, product or medicine; the clinician decides.

Does insurance cover melasma treatment?

Coverage varies by plan. Check each patient’s plan, and do not promise coverage in ads or on the phone.

General information for practice teams, not legal or clinical advice. Check device labeling, FDA requirements, state rules and your advertising with counsel and your clinicians. Last reviewed October 2026.

More resources

All resources for practices

How to get more melasma treatment patients: a plan for practices